Phaseline

Companies › ARJ Medical

ARJ Medical: clinical trials, targets and expected readouts

2 active drug programs in 3 registered trials: 3 Phase 3; Infectious disease.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Comparator Breath Test–Phase 3Helicobacter Pylori Infection–
PyloPlus Urea Breath Test System
Non-radioactive 13C-urea breath test for H. pylori detection
–Phase 3Helicobacter Pylori; Helicobacter Pylori Infection–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT05276557PyloPlus Urea Breath Test SystemPhase 3Helicobacter PyloriInfectious diseaseJun 2023
NCT05681689PyloPlus Urea Breath Test SystemPhase 3Helicobacter Pylori InfectionInfectious diseaseJun 2023
NCT05681689Comparator Breath TestPhase 3Helicobacter Pylori InfectionInfectious diseaseJun 2023

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

National Vaccine and Serum Institute, China NPO Petrovax Xiamen Innovax Biotech MAXVAX Biotechnology Limited Liability Company Catalysis

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.